FR2554448B1 - Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication - Google Patents

Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication

Info

Publication number
FR2554448B1
FR2554448B1 FR8416764A FR8416764A FR2554448B1 FR 2554448 B1 FR2554448 B1 FR 2554448B1 FR 8416764 A FR8416764 A FR 8416764A FR 8416764 A FR8416764 A FR 8416764A FR 2554448 B1 FR2554448 B1 FR 2554448B1
Authority
FR
France
Prior art keywords
manufacture
substituted prostaglandins
furyl derivatives
furyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8416764A
Other languages
English (en)
Other versions
FR2554448A1 (fr
Inventor
Franco Faustini
Achille Panzeri
Fabrizio Orzi
Enrico Di Salle
Roberto Ceserani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of FR2554448A1 publication Critical patent/FR2554448A1/fr
Application granted granted Critical
Publication of FR2554448B1 publication Critical patent/FR2554448B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
FR8416764A 1983-11-04 1984-11-02 Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication Expired FR2554448B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838329559A GB8329559D0 (en) 1983-11-04 1983-11-04 Furyl derivatives of 16-substituted prostaglandins preparations

Publications (2)

Publication Number Publication Date
FR2554448A1 FR2554448A1 (fr) 1985-05-10
FR2554448B1 true FR2554448B1 (fr) 1987-07-24

Family

ID=10551287

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8416764A Expired FR2554448B1 (fr) 1983-11-04 1984-11-02 Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication

Country Status (18)

Country Link
US (1) US4585791A (fr)
JP (1) JPS60112782A (fr)
AU (1) AU563999B2 (fr)
BE (1) BE900959A (fr)
CH (1) CH663413A5 (fr)
DE (1) DE3439863A1 (fr)
DK (1) DK524484A (fr)
FI (1) FI844273L (fr)
FR (1) FR2554448B1 (fr)
GB (2) GB8329559D0 (fr)
GR (1) GR80822B (fr)
HU (1) HU193708B (fr)
IL (1) IL73395A0 (fr)
IT (1) IT1177095B (fr)
NL (1) NL8403307A (fr)
SE (1) SE8405514L (fr)
SU (1) SU1489582A3 (fr)
ZA (1) ZA848551B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5741810A (en) 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US8063033B2 (en) * 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams
US7960378B2 (en) 2008-03-18 2011-06-14 Allergan, Inc. Therapeutic compounds
BRPI0911543A2 (pt) 2008-04-24 2015-10-13 Allergan Inc arilciclopentenos substituídos como agentes terapêuticos
US8263593B2 (en) * 2008-04-24 2012-09-11 Allergan, Inc. Therapeutic compounds
EP2303836A1 (fr) * 2008-05-09 2011-04-06 Allergan, Inc. Dérivés thérapeutiques de cyclopentane
US7981887B2 (en) 2008-05-09 2011-07-19 Allergan, Inc. Therapeutic compounds
WO2009137412A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Composés thérapeutiques
JP2011520807A (ja) * 2008-05-09 2011-07-21 アラーガン インコーポレイテッド 治療用置換ヒダントイン類および関連化合物
EP2875022B1 (fr) * 2012-07-19 2016-10-12 Cayman Chemical Company, Incorporated Composés de difluorolactame comme agonistes sélectifs du récepteur ep4, destinés à être utilisés dans le traitement de maladies et d'affections médiées par ep4

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
NO143741C (no) * 1972-07-13 1981-04-08 Pfizer Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.

Also Published As

Publication number Publication date
AU3494584A (en) 1985-05-09
HU193708B (en) 1987-11-30
BE900959A (fr) 1985-05-02
IL73395A0 (en) 1985-02-28
HUT35637A (en) 1985-07-29
SU1489582A3 (ru) 1989-06-23
DK524484A (da) 1985-05-05
FI844273A0 (fi) 1984-10-31
AU563999B2 (en) 1987-07-30
FR2554448A1 (fr) 1985-05-10
GB2149788A (en) 1985-06-19
GB2149788B (en) 1987-04-08
JPS60112782A (ja) 1985-06-19
SE8405514L (sv) 1985-05-05
DE3439863A1 (de) 1985-05-23
GB8329559D0 (en) 1983-12-07
FI844273L (fi) 1985-05-05
GB8427678D0 (en) 1984-12-05
ZA848551B (en) 1985-06-26
US4585791A (en) 1986-04-29
SE8405514D0 (sv) 1984-11-02
IT8423390A0 (it) 1984-10-30
IT1177095B (it) 1987-08-26
GR80822B (en) 1985-03-04
CH663413A5 (de) 1987-12-15
NL8403307A (nl) 1985-06-03
IT8423390A1 (it) 1986-04-30
DK524484D0 (da) 1984-11-02

Similar Documents

Publication Publication Date Title
FR2551754B1 (fr) Procede de fabrication du 5-hydroxymethylfurfural
FR2550533B1 (fr) Procede pour la fabrication de derives de type penem
FR2540875B1 (fr) Nouveaux derives de la cephalosporine et leur procede de preparation
RO90564A (fr) Procede pour obtenir 1-butene
FR2554685B1 (fr) Procede et installation pour la fabrication de denrees alimentaires extrudees
RO82216A (fr) Procede pour la preparation des derives de 3-aryle-5-tsothiazole
IT8349223A0 (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
FR2568570B1 (fr) Procede pour la fabrication de derives 3-substitues du 1-amino-2-hydroxypropane
FR2554448B1 (fr) Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication
PT70804A (fr) Procede pour la preparation de nouveaux derives heterocicliques
FR2562391B1 (fr) Procede de fabrication de truffes artificielles et composition pour la formation de telles truffes
FR2530422B1 (fr) Production de gelee de pectine
BE870843A (fr) Procede et catalyseur pour la production de polyols et de leurs derives
FR2511681B1 (fr) Procede pour la preparation de derives de 3-exo-methylenecephame
FR2546907B1 (fr) Procede de production de la riboflavine
FR2559771B1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
FR2496650B1 (fr) Procede de production catalytique de diacetate d'ethylidene
RO82087A (fr) Procede pour la preparation de3-pycoline
FR2555155B1 (fr) Titanates de metaux alcalins modifies et procede pour leur preparation
RO82277A (fr) Procede pour la preparation des derives de 11-dodecen-1-yl
FR2533917B1 (fr) Derives 15-cycloaliphatiques de 13,14-bisdeshydro-carboprostacyclines et procede pour leur preparation
RO89141A (fr) Procede pour la preparation des derives de pyrimidintriones
RO87011A (fr) Procede pour la preparation des derives de cyclopentene
FR2523574B1 (fr) Procede pour la fabrication de briques de forsterite et briques de forsterite fabriquees selon ce procede
RO82035A (fr) Procede pour la preparation des derives 1-oxa-beta-lactamiques

Legal Events

Date Code Title Description
ST Notification of lapse